Canadian Centre for Psychedelic Science

Canadian Centre for Psychedelic Science is a Canadian psychedelic research and consulting organization focused on generating rigorous evidence around psychedelic use in mental health. The group appears to operate as a federally incorporated private entity and is conducting a placebo-controlled clinical study of microdosing psilocybin in people with major depression, while also offering consulting services to industry participants. Its public materials emphasize open science, transparent research practices, and early academic work on psychedelic microdosing. The organization is more accurately characterized as a research-focused healthcare company or CRO-like entity than as a traditional therapeutic biotech with a broad proprietary drug pipeline.